Asymptomatic Chlamydia trachomatis (CT) infections are common among sexually active adolescents.1 Routine universal screening is recommended as a strategy to reduce infection rates, associated morbidity, and health care costs.2,3 Confidential CT testing should be available to most adolescent patients who request privacy based on current legal, ethical, and professional guidelines.4 In actual practice, physicians' abilities to guarantee confidential CT testing are often limited because of billing and reimbursement issues.
Ford CA, Best D, Miller WC. Confidentiality and Adolescents' Willingness to Consent to Sexually Transmitted Disease Testing. Arch Pediatr Adolesc Med. 2001;155(9):1072-1073. doi:10.1001/archpedi.155.9.1072